ITGB7 and Miyoshi myopathy: It is worth noting that constitutive activation of ITGB7 has been observed in MM cells but not in non-hematopoietic cells/tissues, making ITGB7 a potential therapeutic target for chimeric antigen receptor (CAR) T cells [33].